Clinical Trial Update: A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pulsed inhaled nitric oxide for pulmonary hypertension associated with pulmonary fibrosis (pulmonary fibrosis with PH).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis
• Pulmonary Hypertension

Drugs mentioned

• pulsed inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Bellerophon | Conditions: Pulmonary Fibrosis, Pulmonary Hypertension | Phase 2 | Status: UNKNOWN